DexTech Medical is a biotechnology research company. Today specialisation is in the area of urologic oncology, where common diseases include prostate cancer. A significant part of the research is carried out in collaboration with international players, research institutes and universities. The company was established in 2004 and is based in Uppsala.
CEO
Chairperson of the Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Svante Wadman | 21,45 | 21,45 | 2024-09-26 |
| Anders Holmberg | 8,51 | 8,51 | 2024-09-26 |
| Sten Nilsson | 7,75 | 7,75 | 2024-09-26 |
| Donald Ericsson Fastigheter VI AB | 6,08 | 6,08 | 2024-09-26 |
| Gösta Lundgren | 5,96 | 5,96 | 2024-09-26 |
| Hans Andersson med familj | 5,60 | 5,60 | 2023-02-20 |
| Nordnet Pensionsförsäkring | 3,77 | 3,77 | 2024-09-26 |
| Avanza Pension | 3,38 | 3,38 | 2024-09-26 |
| Mats Ragnarsson Holmberg | 2,32 | 2,32 | 2024-09-26 |
| Peter Kanekrans | 2,07 | 2,07 | 2024-09-26 |
2025-02-27 Delårsrapport 2025-Q2
2025-04-29 Delårsrapport 2025-Q3
2025-08-30 Bokslutskommuniké 2025
